000			01796 a2200541 4500
005			20250515182005.0
264		0	_c20091123
008			200911s 0 0 eng d
022			_a1932-8737
024	7		_a10.1002/clc.20475 _2doi
040			_aNLM _beng _cNLM
100	1		_aYan, Zhenxian
245	0	0	_aEfficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes. _h[electronic resource]
260			_bClinical cardiology _cSep 2009
300			_aE40-4 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_aAcute Coronary Syndrome _xdrug therapy
650	0	4	_aAged
650	0	4	_aAngioplasty, Balloon, Coronary _xadverse effects
650	0	4	_aBiomarkers _xblood
650	0	4	_aCreatine Kinase, MB Form _xblood
650	0	4	_aDouble-Blind Method
650	0	4	_aElectrocardiography
650	0	4	_aFemale
650	0	4	_aHeart Diseases _xblood
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xadverse effects
650	0	4	_aProspective Studies
650	0	4	_aRisk Assessment
650	0	4	_aThrombocytopenia _xchemically induced
650	0	4	_aTime Factors
650	0	4	_aTirofiban
650	0	4	_aTreatment Outcome
650	0	4	_aTroponin I _xblood
650	0	4	_aTyrosine _xadverse effects
700	1		_aZhou, Yujie
700	1		_aZhao, Yingxin
700	1		_aLi, Yueping
700	1		_aNie, Xiaomin
700	1		_aZhou, Zhiming
700	1		_aJia, Dean
773	0		_tClinical cardiology _gvol. 32 _gno. 9 _gp. E40-4
856	4	0	_uhttps://doi.org/10.1002/clc.20475 _zAvailable from publisher's website
999			_c19052474 _d19052474